Cardiovascular risk in autoimmune disorders: Role of asymmetric dimethylarginine

European Journal of Pharmacology

Volumn 696, Issue 1-3, 2012, Pages 5-11

  Chen, Xu Meng ^a   Hu, Chang Ping ^a   Li, Yuan Jian ^a   Jiang, Jun Lin ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Asymmetric dimethylarginine; Autoimmune disorder; Cardiovascular disease

Indexed keywords

6 N,N' DIMETHYLARGININE; C REACTIVE PROTEIN; CHOLESTEROL; DIMETHYLARGININASE; DOUBLE STRANDED DNA ANTIBODY; GLUCOSE; INSULIN; METFORMIN; N(G) METHYLARGININE; N(G),N(G) DIMETHYLARGININE; NATEGLINIDE; NITRIC OXIDE SYNTHASE; PERINDOPRIL; PROTEIN ARGININE METHYLTRANSFERASE; TELMISARTAN;

AMINO ACID BLOOD LEVEL; ARTERIAL STIFFNESS; ATHEROSCLEROTIC PLAQUE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; DIABETIC NEUROPATHY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; DRUG BLOOD LEVEL; DRUG MECHANISM; DRUG METABOLISM; ENDOTHELIAL DYSFUNCTION; ENZYME INHIBITION; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HUMAN; HYPERTENSION; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; KIDNEY CLEARANCE; KIDNEY FAILURE; MICROALBUMINURIA; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; VASCULAR DISEASE;

ANIMALS; ARGININE; AUTOIMMUNE DISEASES; CARDIOVASCULAR DISEASES; HUMANS; RISK;

EID: 84869084386     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.09.019     Document Type: Review

References (109)

1. F. Abbasi, T. Asagmi, J.P. Cooke, C. Lamendola, T. McLaughlin, G.M. Reaven, M. Stuehlinger, and P.S. Tsao Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus Am. J. Cardiol. 88 2001 1201 1203 (Pubitemid 33043860)
2. V. Achan, M. Broadhead, M. Malaki, G. Whitley, J. Leiper, R. MacAllister, and P. Vallance Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase Arterioscler. Thromb. Vasc. Biol. 23 2003 1455 1459 (Pubitemid 36994536)
3. Y. Adelibieke, H. Shimizu, G. Muteliefu, D. Bolati, and T. Niwa Indoxyl sulfate induces endithelial cell senescence by increase reactive oxygen species production and p53 activity J. Ren. Nutr. 22 2012 86 89
4. A.E. Altinova, M. Arslan, A. Sepici-Dincel, M. Akturk, N. Altan, and F.B. Toruner Uncomplicated type 1 diabetes is associated with increased asymmetric dimethylarginine concentrations J. Clin. Endocrinol. Metab. 92 2007 1881 1885 (Pubitemid 46997204)
5. M. Anderssohn, E. Schwedhelm, N. Lüneburg, R.S. Vasan, and R.H. Böger Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: an intriguing interaction with diabetes mellitus Diabetes Vasc. Dis. Res. 27 2010 105 118
6. C. Antoniades, M. Demosthenous, D. Tousoulis, A.S. Antonopoulos, C. Vlachopoulos, M. Toutouza, K. Marinou, C. Bakogiannis, K. Mavragani, G. Lazaros, N. Koumallos, C. Triantafyllou, D. Lymperiadis, M. Koutsilieris, and C. Stefanadis Role of asymmetrical dimethylarginine in inflammation-induced endothelial dysfunction in human atherosclerosis Hypertension 58 2011 93 98
7. T. Asagami, F. Abbasi, M. Stuelinger, C. Lamendola, T. McLaughlin, J.P. Cooke, G.M. Reaven, and P.S. Tsao Metformin treatment lowers asymmetric dimethylarginine concentrations in patients with type 2 diabetes Metabolism 51 2002 843 846 (Pubitemid 34784808)
8. F. Atzeni, P. Sarzi-Puttini, S. Sitia, L. Tomasoni, L. Gianturco, M. Battellino, L. Boccassini, V. De Gennaro Colonna, A. Marchesoni, and M. Turiel Coronary flow reserve and asymmetric dimethylarginine levels: new measurements for identifying subclinical atherosclerosis in patients with psoriatic arthritis J. Rheumatol. 38 2011 1661 1664
9. J.A. Avina-Zubieta, H.K. Choi, M. Sadatsafavi, M. Etminan, J.M. Esdaile, and D. Lacaille Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies Arthritis Rheum. 59 2008 1690 1697
10. J. Bełtowski, and A. Kedra Asymmetric dimethylarginine (ADMA) as a target for pharmacotherapy Pharmacol. Rep. 58 2006 159 178
11. S. Blaise, R. Maas, C. Trocme, G.D. Kom, M. Roustit, P.H. Carpentier, and J.L. Cracowski Correlation of biomarkers of endothelium dysfunction and matrix remodeling in patients with systemic sclerosis J. Rheumatol. 36 2009 984 988
12. R.H. Böger, L.M. Sullivan, E. Schwedhelm, T.J. Wang, R. Maas, E.J. Benjamin, F. Schulze, V. Xanthakis, R.A. Benndorf, and R.S. Vasan Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community Circulation 119 2009 1592 1600
13. T. Brunini, M. Moss, M. Siqueira, L. Meirelles, A. Rozentul, G. Mann, J. Ellory, R. Soares de Moura, and A. Mendes-Ribeiro Inhibition of l-arginine transport in platelets by asymmetric dimethylarginine and N-monomethyl-l- arginine: effects of arterial hypertension Clin. Exp. Pharmacol. Physiol. 31 2004 738 740 (Pubitemid 39540326)
14. I.E. Bultink, T. Teerlink, J.A. Heijst, B.A. Dijkmans, and A.E. Voskuyl Raised plasma levels of asymmetric dimethylarginine are associated with cardiovascular events, disease activity, and organ damage in patients with systemic lupus erythematosus Ann. Rheum. Dis. 64 2005 1362 1365 (Pubitemid 41206260)
15. M.F. Chen, X.M. Xie, T.L. Yang, Y.J. Wang, X.H. Zhang, B.L. Luo, and Y.J. Li Role of asymmetric dimethylarginine in inflammatory reactions by angiotensin II J. Vasc. Res. 44 2007 391 402
16. S.C. Croca, and A. Rahman Imaging assessment of cardiovascular disease in systemic lupus erythematosus Clin. Dev. Immunol. 2012 2012 694143
17. L. Czirjak, G. Kumánovics, C. Varjú, Z. Nagy, A. Pákozdi, Z. Szekanecz, and G. Szucs Survival and causes of death in 366 Hungarian patients with systemic sclerosis Ann. Rheum. Dis. 67 2008 59 63
18. E. Devangelio, F. Santilli, G. Formoso, P. Ferroni, L. Bucciarelli, N. Michetti, C. Clissa, G. Ciabattoni, A. Consoli, and G. Davì Soluble RAGE in type 2 diabetes: association with oxidative stress Free Radical Biol. Med. 43 2007 511 518 (Pubitemid 47058227)
19. T. Dimitroulas, G. Giannakoulas, K. Papadopoulou, H. Karvounis, H. Dimitroula, G. Koliakos, T. Karamitsos, D. Parcharidou, and L. Settas Early detection of cardiac involvement in systemic sclerosis assessed by tissue-Doppler echocardiography: relationship with neurohormonal activation and endothelial dysfunction J. Rheumatol. 37 2010 993 999
20. T. Dimitroulas, G. Giannakoulas, K. Papadopoulou, T. Sfetsios, H. Karvounis, H. Dimitroula, D. Parcharidou, G. Koliakos, A. Garyfallos, I. Styliadis, and L. Settas Left atrial volume and N-terminal pro-B type natriuretic peptide are associated with elevated pulmonary artery pressure in patients with systemic sclerosis Clin. Rheumatol. 29 2010 957 964
21. T. Dimitroulas, G. Giannakoulas, T. Sfetsios, H. Karvounis, H. Dimitroula, G. Koliakos, and L. Settas Asymmetrical dimethylarginine in systemic sclerosis-related pulmonary arterial hypertension Rheumatology (Oxford) 47 2008 1682 1685
22. A. Dooley, B. Gao, N. Bradley, D.J. Abraham, C.M. Black, M. Jacobs, and K.R. Bruckdorfer Abnormal nitric oxide metabolism in systemic sclerosis: increased levels of nitrated proteins and asymmetric dimethylarginine Rheumatology (Oxford) 45 2006 676 684 (Pubitemid 43985335)
23. H.M. Eid, H. Reims, H. Arnesen, S.E. Kjeldsen, T. Lyberg, and I. Seljeflot Decreased levels of asymmetric dimethylarginine during acute hyperinsulinemia Metabolism 56 2007 464 469 (Pubitemid 46427842)
24. B. Ellger, M.C. Richir, P.A. van Leeuwen, Y. Debaveye, L. Langouche, I. Vanhorebeek, T. Teerlink, and G. Van den Berghe Glycemic control modulates arginine and asymmetrical dimethylarginine levels during critical illness by preserving dimethylarginine-dimethylaminohydrolase activity Endocrinology 149 2008 3148 3157 (Pubitemid 351724509)
25. G.L. Erre, P. Sanna, A. Zinellu, A. Ponchietti, P. Fenu, S. Sotgia, C. Carru, A. Ganau, and G. Passiu Plasma asymmetric dimethylarginine (ADMA) levels and atherosclerotic disease in ankylosing spondylitis: a cross-sectional study Clin. Rheumatol. 30 2011 21 27
26. A. Fujimi-Hayashida, S. Ueda, S. Yamagishi, Y. Kaida, R. Ando, Y. Nakayama, K. Fukami, and S. Okuda Association of asymmetric dimethylarginine with severity of kidney injury and decline in kidney function in IgA nephropathy Am. J. Nephrol. 33 2011 1 6
27. H.W. Gao, C. Xie, H.N. Wang, Y.H. Lin, and T.P. Hong Beneficial metabolic effects of nateglinide versus acarbose in patients with newly-diagnosed type 2 diabetes Acta Pharmacol. Sin. 28 2007 534 539 (Pubitemid 46496085)
28. J.D. Gary, and S. Clarke RNA and protein interaction modulated by protein arginine methylation Prog. Nucleic Acid Res. Mol. Biol. 61 1998 65 131
29. R. Gerli, B.E. Bartoloni, Y. Sherer, G. Vaudo, S. Moscatelli, and Y. Shoenfeld Association of anti-cyclic citrullinated peptide antibodies with subclinical atherosclerosis in patients with rheumatoid arthritis Ann. Rheum. Dis. 67 2008 724 725 (Pubitemid 351571944)
30. B. Głowińska-Olszewska, W. Luczyński, J. Jabłońska, A. Otocka, B. Florys, and A. Bossowski Asymmetric dimethylarginine (ADMA) in children with diabetes type 1 Pediatr. Endocrinol. Diabetes Metab. 16 2010 137 141
31. M. Gonzalez, C. Flores, J.D. Pearson, P. Casanello, and L. Sobrevia Cell signalling mediating insulin increase of mRNA expression for cationic amino acid transporters-1 and -2 and membrane hyperpolarization in human umbilical vein endothelial cells Pflugers Arch. 448 2004 383 394 (Pubitemid 39006002)
32. L.Q. Gu, L. Zhao, W. Zhu, F.Y. Li, M.J. Zhang, Y. Liu, J.M. Liu, G. Ning, and Y.J. Zhao Relationships between serum levels of thyroid hormones and serum concentrations of asymmetric dimethylarginine (ADMA) and N-terminal-pro-B-type natriuretic peptide (NT-proBNP) in patients with Graves' disease Endocrine 39 2011 266 271
33. M. Huemer, B. Simma, D. Mayr, A. Mühl, B. Rami, E. Schober, H. Ulmer, U. Zanier, and O.A. Bodamer Low levels of asymmetric dimethylarginine in children with diabetes mellitus type I compared with healthy children J. Pediatr. 158 4 2011 602 606
34. K. Heilman, M. Zilmer, K. Zilmer, P. Kool, and V. Tillmann Elevated plasma adiponectin and decreased plasma homocysteine and asymmetric dimethylarginine in children with type 1 diabetes Scand. J. Clin. Lab. Invest. 69 2009 85 91
35. A. Ito, K. Egashira, T. Narishige, K. Muramatsu, and A. Takeshita Angiotensin-converting enzyme activity is involved in the mechanism of increased endogenous nitric oxide synthase inhibitor in patients with type 2 diabetes mellitus Circ. J. 66 2002 811 815
36. M. Ivanova, C. Artusi, G.M. Boffa, M. Zaninotto, and M. Plebani HPLC determination of plasma dimethylarginines: method validation and preliminary clinical application Clin. Chim. Acta 411 2010 1632 1636
37. J.L. Jiang, N.S. Li, Y.J. Li, and H.W. Deng Probucol preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level Br. J. Pharmacol. 135 2002 1175 1182
38. C.Y. Karabay, T. Karaahmet, and K. Tigen Cardiovascular involvement in patients with systemic sclerosis: insights from electromechanical characteristics of the heart Anadolu Kardiyol Derg. 11 2011 643 647
39. Á. Kemény-Beke, R. Gesztelyi, N. Bodnár, J. Zsuga, G. Kerekes, M. Zsuga, B. Biri, S. Kéki, P. Szodoray, A. Berta, Z. Szekanecz, and S. Szántó Increased production of asymmetric dimethylarginine (ADMA) in ankylosing spondylitis: association with other clinical and laboratory parameters Jt. Bone Spine 78 2011 184 187
40. A.N. Kiani, J.A. Mahoney, and M. Petri Asymmetric dimethylarginine is a marker of poor prognosis and coronary calcium in systemic lupus erythematosus J. Rheumatol. 34 2007 1502 1505 (Pubitemid 47067986)
41. D. Konukoglu, S. Firtina, and O. Serin The relationship between plasma asymmetrical dimethyl-l-arginine and inflammation and adhesion molecule levels in subjects with normal, impaired, and diabetic glucose tolerance Metabolism 57 2008 110 115 (Pubitemid 350234980)
42. V. Kostourou, H. Troy, J.F. Murray, E.R. Cullis, G.S. Whitley, J.R. Griffiths, and S.P. Robinson Overexpression of dimethylarginine dimethylaminohydrolase enhances tumor hypoxia: an insight into the relationship of hypoxia and angiogenesis in vivo Neoplasia 6 2004 401 411 (Pubitemid 38924855)
43. M.B. Landim, A. Casella Filho, and A.C. Chagas Asymmetric dimethylarginine (ADMA) and endothelial dysfunction: implications for atherogenesis Clinics (Sao Paulo) 64 2009 471 478
44. J.M. Leiper, J. Santa Maria, A. Chubb, R.J. MacAllister, I.G. Charles, G.S. Whitley, and P. Vallance Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases Biochem. J. 343 1999 209 214 (Pubitemid 29473897)
45. X.H. Li, J. Peng, N. Tan, W.H. Wu, T.T. Li, R.Z. Shi, and Y.J. Li Involvement of asymmetric dimethylarginine and Rho kinase in the vascular remodeling in monocrotaline-induced pulmonary hypertension Vascul. Pharmacol. 53 2010 223 229
46. K.Y. Lin, A. Ito, T. Asagami, P.S. Tsao, S. Adimoolam, M. Kimoto, H. Tsuji, G.M. Reaven, and J.P. Cooke Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase Circulation 106 2002 987 992 (Pubitemid 34925335)
47. S.S. Lund, L. Tarnow, C.D. Stehouwer, C.G. Schalkwijk, T. Teerlink, J. Gram, K. Winther, M. Frandsen, U.M. Smidt, O. Pedersen, H.H. Parving, and A.A. Vaag Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes Eur. J. Endocrinol. 158 2008 631 641 (Pubitemid 351639600)
48. Z. Luo, T. Teerlink, K. Griendling, S. Aslam, W.J. Welch, and C.S. Wilcox Angiotensin II and NADPH oxidase increase ADMA in vascular smooth muscle cells Hypertension 56 2010 498 504
49. E. Mah, S.K. Noh, K.D. Ballard, M.E. Matos, J.S. Volek, and R.S. Bruno Postprandial hyperglycemia impairs vascular endothelial function in healthy men by inducing lipid peroxidation and increasing asymmetric dimethylarginine: arginine J. Nutr. 141 2011 1961 1968
50. L. Mallbris, O. Akre, F. Granath, L. Yin, B. Lindelöf, A. Ekbom, and M. Ståhle-Bäckdahl Increased risk for cardiovascular mortality in psoriasis in patients but not in outpatients Eur. J. Epidemiol. 19 2004 225 230 (Pubitemid 38461682)
51. M.L. Marcovecchio, B. Widmer, D.B. Dunger, and R.N. Dalton Effect of acute variations of insulin and glucose on plasma concentrations of asymmetric dimethylarginine in young people with type 1 diabetes Clin. Sci. 115 2008 361 369
52. J. Martens-Lobenhoffer, R.N. Rodionov, A. Drust, and S.M. Bode-Böger Detection and quantification of α-keto-δ-(N(G),N(G)- dimethylguanidino)valeric acid: a metabolite of asymmetric dimethylarginine Anal. Biochem. 419 2011 234 240
53. H. Masuda, M. Goto, S. Tamaoki, and H. Azuma Accelerated intimal hyperplasia and increased endogenous inhibitors for NO synthesis in rabbits with alloxan-induced hyperglycemia Br. J. Pharmacol. 126 1999 211 218 (Pubitemid 29041760)
54. S. Mathieu, L. Gossec, M. Dougados, and M. Soubrier Cardiovascular profile in ankylosing spondylitis: a systematic review and meta-analysis Arthritis Care Res. (Hoboken) 63 2011 557 563
55. E. Matsuura, K. Kobayashi, M. Tabuchi, and L.R. Lopez Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis Prog. Lipid. Res. 45 2006 466 486 (Pubitemid 44331411)
56. L.J. Millatt, G.S. Whitley, D. Li, J.M. Leiper, H.M. Siragy, R.M. Carey, and R.A. Johns Evidence for dysregulation of dimethylarginine dimethylaminohydrolase I in chronic hypoxia-induced pulmonary hypertension Circulation 108 2003 1493 1498 (Pubitemid 37176457)
57. U. Müller-Ladner, O. Distler, L. Ibba-Manneschi, E. Neumann, and S. Gay Mechanisms of vascular damage in systemic sclerosis Autoimmunity 42 2009 587 595
58. J. Murray-Rust, J. Leiper, M. McAlister, J. Phelan, S. Tilley, J. Santa Maria, P. Vallance, and N. McDonald Structural insights into the hydrolysis of cellular nitric oxide synthase inhibitors by dimethylarginine dimethylaminohydrolase Nat. Struct. Biol. 8 2001 679 683 (Pubitemid 32757926)
59. U. Nussinovitch, and Y. Shoenfeld Atherosclerosis and macrovascular involvement in systemic sclerosis: myth or reality Autoimmun. Rev. 10 2011 259 266
60. S.L. Nuttall, S. Heaton, M.K. Piper, U. Martin, and C. Gordon Cardiovascular risk in systemic lupus erythematosus-evidence of increased oxidative stress and dyslipidaemia Rheumatology (Oxford) 42 2003 758 762 (Pubitemid 37220907)
61. T. Ogawa, M. Kimoto, and K. Sasaoka Purification and properties of a new enzyme, N, N-dimethylarginine dimethylaminohydrolase, from rat kidney J. Biol. Chem. 264 1989 10205 10209 (Pubitemid 19159295)
62. M.L. Onozato, A. Tojo, J. Leiper, T. Fujita, F. Palm, and C.S. Wilcox Expression of NG, NG-dimethylarginine dimethylaminohydrolase and protein arginine N-methyltransferase isoforms in diabetic rat kidney: effects of angiotensin II receptor blockers Diabetes 57 2008 172 180
63. H. Päivä, T. Lehtimäki, J. Laakso, I. Ruokonen, V. Rantalaiho, O. Wirta, A. Pasternack, and R. Laaksonen Plasma concentrations of asymmetric-dimethyl-arginine in type 2 diabetes associate with glycemic control and glomerular filtration rate but not with risk factors of vasculopathy Metabolism 52 2003 303 307 (Pubitemid 36406325)
64. F. Palm, M. Friederich, P.O. Carlsson, P. Hansell, T. Teerlink, and P. Liss Reduced nitric oxide in diabetic kidneys due to increased hepatic arginine metabolism: implications for renomedullary oxygen availability Am. J. Physiol. Ren. Physiol. 294 2008 F30 F37
65. D.A. Pappas, L. Geraldino-Pardilla, and J.M. Bathon Immune modulation of rheumatoid arthritis Best Pract. Res. Clin. Rheumatol. 25 2011 873 889
66. M. Perna, M.J. Roman, D.R. Alpert, M.K. Crow, M.D. Lockshin, L. Sammaritano, R.B. Devereux, J.P. Cooke, and J.E. Salmon Relationship of asymmetric dimethylarginine and homocysteine to vascular aging in systemic lupus erythematosus patients Arthritis Rheum. 62 2010 1718 1722
67. H. Pieringer, and M. Pichler Cardiovascular morbidity and mortality in patients with rheumatoid arthritis: vascular alterations and possible clinical implications QJM 104 2011 13 26
68. D. Pitocco, F. Zaccardi, E. Di Stasio, F. Romitelli, F. Martini, G.L. Scaglione, D. Speranza, S. Santini, C. Zuppi, and G. Ghirlanda Role of asymmetric-dimethyl-l-arginine (ADMA) and nitrite/nitrate (NOx) in the pathogenesis of oxidative stress in female subjects with uncomplicated type 1 diabetes mellitus Diabetes Res. Clin. Pract. 86 2009 173 176
69. R. Ramonda, A. Lo Nigro, V. Modesti, L. Nalotto, E. Musacchio, L. Iaccarino, L. Punzi, and A. Doria Atherosclerosis in psoriatic arthritis Autoimmun. Rev. 10 2011 773 778
70. P. Ravani, G. Tripepi, F. Malberti, S. Testa, F. Mallamaci, and C. Zoccali Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach J. Am. Soc. Nephrol. 16 2005 2449 2455 (Pubitemid 41725063)
71. N. Rawal, R. Rajpurohit, M.A. Lischwe, K.R. Williams, W.K. Paik, and S. Kim Structural specificity of substrate for S-adenosylmethionine: protein arginine N-methyltransferases Biochim. Biophys. Acta 1248 1995 11 18
72. R.N. Rodionov, D.J. Murry, S.F. Vaulman, J.W. Stevens, and S.R. Lentz Human alanine-glyoxylate aminotransferase 2 lowers asymmetric dimethylarginine and protects from inhibition of nitric oxide production J. Biol. Chem. 285 2010 5385 5391
73. A. Sandoo, J.J. Veldhuijzen van Zanten, G.S. Metsios, D. Carroll, and G.D. Kitas Vascular function and morphology in rheumatoid arthritis: a systematic review Rheumatology (Oxford) 50 2011 2125 2139
74. I. Sari, L. Kebapcilar, A. Alacacioglu, O. Bilgir, Y. Yildiz, A. Taylan, A. Yuksel, and D.L. Kozaci Increased levels of asymmetric dimethylarginine (ADMA) in patients with ankylosing spondylitis Intern. Med. 48 2009 1363 1368
75. N. Sattar, D.W. McCarey, H. Capell, and I.B. Mclnnes Explaining how high-grade systemic inflammation accelerates vascular risk in rheumatoid arthritis Circulation 108 2003 2957 2963 (Pubitemid 37553561)
76. E. Schwedhelm Quantification of ADMA: analytical approaches Vasc. Med. 10 Suppl 1 2005 S89 S95
77. Y. Sherer, H. Zinger, and Y. Shoenfeld Atherosclerosis in systemic lupus erythematosus Autoimmunity 43 2010 98 102
78. L. Sibal, S.C. Agarwal, E. Schwedhelm, N. Lüneburg, R.H. Böger, and P.D. Home A study of endothelial function and circulating asymmetric dimethylarginine levels in people with Type 1 diabetes without macrovascular disease or microalbuminuria Cardiovasc. Diabetol. 8 2009 27
79. M. Siervo, M. Corander, S. Stranges, and L. Bluck Post-challenge hyperglycemia, nitric oxide production and endothelial dysfunction: the putative role of asymmetric dimethylarginine (ADMA) Nutr. Metab. Cardiovasc. Dis. 21 2011 1 10
80. W.W. Simmons, E.I. Closs, J.M. Cunningham, T.W. Smith, and R.A. Kelly Cytokines and insulin induce cationic amino acid transporter (CAT) expression in cardiac myocytes J. Biol. Chem. 271 1996 11694 11702
81. M.P. Siroen, P.A. van Leeuwen, R.J. Nijveldt, T. Teerlink, P.T. Wouters, and G. van den Berghe Modulation of asymmetric dimethylarginine in critically ill patients receiving intensive insulin treatment: A possible explanation of reduced morbidity and mortality? Crit. Care Med. 33 2005 504 510 (Pubitemid 40365549)
82. P.P. Smith, and C. Gordon Systemic lupus erythematosus: clinical presentations Autoimmun. Rev. 10 2010 43 45
83. P. Soltész, G. Kerekes, H. Dér, G. Szücs, S. Szántó, E. Kiss, E. Bodolay, M. Zeher, O. Timár, P. Szodoray, G. Szegedi, and Z. Szekanecz Comparative assessment of vascular function in autoimmune rheumatic diseases: considerations of prevention and treatment Autoimmun. Rev. 10 2011 416 425
84. M.C. Stühlinger, F. Abbasi, J.W. Chu, C. Lamendola, T.L. Mclauqhin, J.P. Cooke, G.M. Reaven, and P.S. Tsao Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor J. Am. Med. Assoc. 287 2002 1420 1426 (Pubitemid 34250505)
85. M.C. Stühlinger, P.S. Tsao, J.H. Her, M. Kimoto, R.F. Balint, and J.P. Cooke Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine Circulation 104 2001 2569 2575 (Pubitemid 33104795)
86. A. Surdacki, J. Martens-Lobenhoffer, A. Wloch, P. Gluszko, T. Rakowski, J.S. Dubiel, and S.M. Bode-Böger Plasma asymmetric dimethylarginine is related to anticitrullinated protein antibodies in rheumatoid arthritis of short duration Metabolism 58 2009 316 318
87. A. Surdacki, J. Martens-Lobenhoffer, A. Wloch, E. Marewicz, T. Rakowski, E. Wieczorek-Surdacka, J.S. Dubiel, J. Pryjma, and S.M. Bode-Böger Elevated plasma asymmetric dimethyl-l-arginine levels are linked to endothelial progenitor cell depletion and carotid atherosclerosis in rheumatoid arthritis Arthritis Rheum. 256 2007 809 819 (Pubitemid 46399428)
88. K. Sydow, C.E. Mondon, J. Schrader, H. Konishi, and J.P. Cooke Dimethylarginine dimethylaminohydrolase overexpression enhances insulin sensitivity Arterioscler. Thromb. Vasc. Biol. 28 2008 692 697 (Pubitemid 351651348)
89. G. Szucs, O. Tímár, Z. Szekanecz, H. Dér, G. Kerekes, S. Szamosi, Y. Shoenfeld, G. Szegedi, and P. Soltész Endothelial dysfunction precedes atherosclerosis in systemic sclerosis - relevance for prevention of vascular complications Rheumatology (Oxford) 46 2007 759 762 (Pubitemid 47061704)
90. Y.L. Tain, and L.T. Huang Asymmetric dimethylarginine: clinical applications in pediatric medicine J. Formos Med. Assoc. 110 2011 70 77
91. T. Tarr, G. Lakos, H.P. Bhattoa, P. Soltesz, Y. Shoenfeld, G. Szegedi, and E. Kiss Clinical thrombotic manifestations in Systemic lupus erythematosus patients with and without antiphospholipid antibodies: a 5-year follow-up Clin. Rev. Allergy Immunol. 32 2007 131 137 (Pubitemid 47571435)
92. T. Thum, D. Tsikas, S. Stein, M. Schultheiss, M. Eigenthaler, S.D. Anker, P.A. Poole-Wilson, G. Ertl, and J. Bauersachs Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine J. Am. Coll. Cardiol. 46 2005 1693 1701 (Pubitemid 41531624)
93. C.T. Tran, M.F. Fox, P. Vallance, and J.M. Leiper Chromosomal localization, gene structure, and expression pattern of DDAH1: comparison with DDAH2 and implications for evolutionary origins Genomics 68 2000 101 105
94. M. Turiel, F. Atzeni, L. Tomasoni, S. de Portu, L. Delfino, B.D. Bodini, M. Longhi, S. Sitia, M. Bianchi, P. Ferrario, A. Doria, V. De Gennaro Colonna, and P. Sarzi-Puttini Non-invasive assessment of coronary flow reserve and ADMA levels: a case-control study of early rheumatoid arthritis patients Rheumatology (Oxford) 48 2009 834 839
95. M. Turiel, L. Tomasoni, S. Sitia, S. Cicala, L. Gianturco, C. Ricci, F. Atzeni, V. De Gennaro Colonna, M. Longhi, and P. Sarzi-Puttini Effects of long-term disease-modifying antirheumatic drugs on endothelial function in patients with early rheumatoid arthritis Cardiovasc. Ther. 28 2010 e53 e64
96. H.A. Uchida, Y. Nakamura, M. Kaihara, H. Norii, Y. Hanayama, H. Sugiyama, Y. Maeshima, Y. Yamasaki, and H. Makino Steroid pulse therapy impaired endothelial function while increasing plasma high molecule adiponectin concentration in patients with IgA nephropathy Nephrol. Dial. Transplant. 21 2006 3475 3480 (Pubitemid 44817097)
97. A. Villa-Forte, and B.F. Mandell Cardiovascular disorders and rheumatic disease Rev. Esp. Cardiol. 64 2011 809 817
98. N.S. Wade, and A.S. Major The problem of accelerated atherosclerosis in systemic lupus erythematosus: insights into a complex co-morbidity Thromb. Haemost. 106 2011 849 857
99. S. Wakino, K. Hayashi, S. Tatematsu, K. Hasegawa, I. Takamasu, T. Kanda, K. Homma, K. Yoshioka, N. Sugano, and T. Saruta Pioglitazone lowers systemic asymmetric dimethylarginine by inducing dimethylarginine dimethylaminohydrolase in rats Hypertens. Res. 28 2005 255 262 (Pubitemid 40812611)
100. A.Y. Wang Cardiovascular risk in diabetic end-stage renal disease patients J. Diabetes 3 2011 119 131
101. D. Wang, P.S. Gill, T. Chabrashvili, M.L. Onozato, J. Raggio, M. Mendonca, K. Dennehy, M. Li, P. Modlinger, J. Leiper, P. Vallance, O. Adler, A. Leone, A. Tojo, W.J. Welch, and C.S. Wilcox Isoform-specific regulation by N(G),N(G)-dimethylarginine dimethylaminohydrolase of rat serum asymmetric dimethylarginine and vascular endothelium-derived relaxing factor/NO Circ. Res. 101 2007 627 635 (Pubitemid 351325880)
102. C.S. Wilcox Asymmetric dimethylarginine and reactive oxygen species: unwelcome twin visitors to the cardiovascular and kidney disease tables Hypertension 59 2012 375 381
103. D.A. Winer, S. Winer, L. Shen, P.P. Wadia, J. Yantha, G. Paltser, H. Tsui, P. Wu, M.G. Davidson, M.N. Alonso, H.X. Leong, A. Glassford, M. Caimol, J.A. Kenkel, T.F. Tedder, T. McLaughlin, D.B. Miklos, H.M. Dosch, and E.G. Engleman B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies Nat. Med. 17 2011 610 617
104. J. Wipff, J. Avouac, D. Borderie, D. Zerkak, H. Lemarechal, A. Kahan, C. Boileau, and Y. Allanore Disturbed angiogenesis in systemic sclerosis: high levels of soluble endoglin Rheumatology (Oxford) 47 2008 972 975 (Pubitemid 351865917)
105. Y. Xiong, Y. Fu, S. Fu, and H. Zhou Elevated levels of the serum endogenous inhibitor of nitric oxide synthase and metabolic control in rats with streptozotocin-induced diabetes J. Cardiovasc. Pharmacol. 42 2003 191 196 (Pubitemid 36899670)
106. Y. Xiong, M. Lei, S. Fu, and Y. Fu Effect of diabetic duration on serum concentrations of endogenous inhibitor of nitric oxide synthase in patients and rats with diabetes Life Sci. 77 2005 149 159 (Pubitemid 40603500)
107. K. Yanaba, J.D. Bouaziz, T. Matsushita, C.M. Magro St, E.W. Clair, and T.F. Tedder B-lymphocyte contributions to human autoimmune disease Immunol. Rev. 223 2008 284 299 (Pubitemid 351986191)
108. M. Yokoro, M. Suzuki, M. Yatani, H. Yamashita, Y. Takahashi, H. Tsuji, and M. Kimoto Development of an enzyme-linked immunosorbent assay system for the determination of asymmetric dimethylarginine using a specific monoclonal antibody Biosci. Biotechnol. Biochem. 76 2012 400 403
109. Q. Yuan, J. Peng, S.Y. liu, C.J. Wang, D.X. Xiang, X.M. Xiong, C.P. Hu, and Y.J. Li Inhibitory effect of resveratrol derivative BTM-0512 on high glucose-induced cell senescence involves dimethylaminohydrolase/asymmetric dimethylarginine pathway. Clin. Exp. Pharmacol. Physiol. 37 2010 630 635